Prev      Next

Practice Management Considerations for LipiView, DMI, and LipiFlow - TearScience

Last updated on July 15, 2015

© 2015 Corcoran Consulting Group. All rights reserved.

Question 2:

What is Dynamic Meibomian Imaging™ (DMI™)?

Answer:

Dynamic Meibomian Imaging (DMI) employs two novel imaging technologies: dynamic illumination and adaptive transillumination. Each technology generates its own independent image of the glands which is then processed, displayed and combined to provide a more accurate visualization of meibomian gland structure. Using these images, the ophthalmologist or optometrist can detect structural change in the meibomian glands. As MGD progresses, DMI reveals gland truncation and dilation in moderate disease followed by gland atrophy and drop out in the most severe disease.

    

The reader is strongly encouraged to review federal and state laws, regulations, code sets (including ICD-10), and official instructions promulgated by Medicare and other payers. This document is not an official source nor is it a complete guide on reimbursement. The reader is reminded that this information, including references and hyperlinks, changes over time, and may be incorrect at any time following publication.

© 2015 Corcoran Consulting Group. All rights reserved. No part of this publication may be reproduced or distributed in any form or by any means, or stored in a retrieval system, without the written permission of the publisher. CPT is a registered trademark of the American Medical Association. Corcoran Consulting Group (800) 399-6565 | www.corcoranccg.com